HighPoint Advisor Group’s Teva Pharmaceuticals TEVA Stock Holding History

HighPoint Advisor Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$509K	Buy
2021 Q3	$98K	Buy
2019 Q3	–	Sell
2019 Q2	$95K	Sell
2019 Q1	$188K	Buy
2018 Q4	$214K	Buy
2018 Q3	$228K	Buy
2017 Q1	–	Sell
2016 Q4	$219K	Buy
2016 Q3	$204K	Buy
2016 Q2	$231K	Buy